Medibotics LLC recently secured a major technological breakthrough with the issuance of U.S. Patent No. 12721524. This patent, titled ‘Biometric wearable device (e.g. finger ring or smart watch) with optical sensors and body-facing protrusions’, introduces a structural improvement for health tracking hardware. Invented by Robert A. Connor, the technology addresses the common issue of inaccurate readings caused by poor sensor contact. The design features small protrusions that gently press into the user’s skin, which stabilizes the sensor and shields it from external light.
Enhanced Accuracy for Wearable Biometrics
The innovation focuses on optimizing the interface between a biometric device and the human body. This system uses body-facing protrusions surrounding the optical sensors to ensure consistent contact, even during physical activity. By preventing ambient light from interfering with the photodetectors, the device captures a clearer signal. This setup allows for highly reliable and continuous monitoring of vital signs, such as heart rate and blood oxygen levels, regardless of user movement. The structural change provides a significant upgrade over traditional flat-backed wearables.
Minnesota Patent of the Month Award
This invention was selected as the patent of the month for the Minnesota state for the month of October 2026 granted by Swanson Reed. The recognition highlights the practical approach Medibotics LLC and inventor Robert A. Connor took to solve a widespread technical limitation in consumer health devices. Swanson Reed commended the patent for its clear utility and immediate applicability in the rapidly expanding wearable technology market, noting that the physical protrusions offer a simple yet highly effective solution to complex signal noise problems.
R&D Tax Credit Eligibility in the USA
The practical applications of this patent present a strong case for companies to claim the Research and Development (R&D) tax credit in the USA. Integrating this patented design into commercial products requires extensive prototyping to determine the optimal size, shape, and material of the protrusions for maximum user comfort and sensor efficacy. Companies must also conduct clinical trials across diverse user demographics to validate the improved accuracy of the optical sensors. The iterative testing processes, along with the development of new software algorithms to interpret the enhanced biometric data, involve resolving significant technical uncertainties. These systematic engineering efforts directly align with the core requirements of the R&D tax credit, allowing businesses to recover a portion of their qualified research expenditures.
